Viewing nowQusetas Tablet 20 mg (Jastaprazan Citrate)
Zastaprazan Citrate 20mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202400968 · Approved 2024.04.25 · Insurance code 645406450
Treatment of erosive gastroesophageal reflux disease and gastric ulcers
This medication is used for the treatment of erosive gastroesophageal reflux disease and gastric ulcer.
This medicine is administered to adults as follows. It may be taken with or without food. 1. Treatment of erosive gastroesophageal reflux disease - Administer 20 mg orally once daily for 4 weeks. If the condition is not resolved, continue treatment for an additional 4 weeks. 2. Treatment of gastric ulcers - Administer 20 mg orally once daily for up to 8 weeks.
This drug should not be used in certain patients. Patients who have allergies or have experienced hypersensitivity reactions to this drug or its components, as well as those taking certain antiviral medications (Atazanavir, Nelfinavir, Rilpivirine) should not take this drug. Women who are pregnant or breastfeeding should also not use this medication. Additionally, since this drug contains lactose, patients with lactose intolerance or hereditary lactose-related diseases should not take it. Patients with liver or kidney function issues, as well as the elderly, should use this drug with caution, as its safety in these patients has not been adequately confirmed. Various gastrointestinal side effects may occur when taking this medication, and adverse reactions such as headaches, myalgia, skin rashes, and sleep disturbances have been reported. Prolonged use of this medication may lead to hypomagnesemia, vitamin B12 deficiency, and an increased risk of fractures related to osteoporosis, necessitating regular check-ups. This drug suppresses stomach acid and may slightly increase the risk of bacterial infection in the stomach; consult a doctor if diarrhea persists. Furthermore, this drug may interact with other medications, so it is essential to inform your doctor about any current medications. Pregnant or breastfeeding women should not take this medication and should consult a healthcare professional if needed. The safety for children and adolescents has not been adequately confirmed, so caution should be exercised in their use. This medication should be kept out of the reach of children, and changing the storage container should be avoided. There is no specific treatment for overdose, but symptoms should be monitored, and necessary treatment should be obtained. The effects of this medication on driving or operating machinery are unclear, but caution should be taken considering the possibility of adverse reactions.
Hernia, dyspepsia, chronic gastritis, erosive gastritis, nausea, abdominal distension, abdominal pain, epigastric pain, diarrhea, duodenal polyp, discomfort in the upper abdomen, meteorism, food poisoning, gastric polyp, gastritis, hemorrhoids, intestinal metaplasia, esophageal dysplasia, oral paresthesia, vomiting, duodenitis, constipation, hypergastrinemia, COVID-19, shingles, bronchitis, trichoblastoma, headache, radiculopathy, tension headache, tremor, migraine, drowsiness, arthralgia, intervertebral disc disorder of the spine, muscle spasm, limb pain, elevated alanine aminotransferase, elevated aspartate aminotransferase, increased blood bilirubin, increased blood creatine phosphokinase, increased blood lactate dehydrogenase, elevated gamma-glutamyl transferase, increased post-void residual volume, weight gain, increased blood gastrin, hypertriglyceridemia, hyperkalemia, hyperlipidemia, rash, pruritus, asthenia, thirst, pain, conjunctival deposits, dry eye syndrome, ligament sprain, bruise, skin laceration, sleep disorder, thyroid nodule, atrial fibrillation, thrombophlebitis, hematuria, renal cyst, dysmenorrhea, epigastric pain, gastroesophageal reflux disease, nausea, colorectal polyp, erosive gastritis, abdominal discomfort, intestinal metaplasia, gingival swelling, belching, passage of bloody stools, abdominal pain, duodenitis, green nail syndrome, nasopharyngitis, influenza, pulmonary tuberculosis, dizziness, lumbar radiculopathy, osteoarthritis, back pain, arthralgia, plantar fasciitis, hyperlipidemia, chest pain, allergic conjunctivitis, keratitis, fibula fracture, hyperplastic gallbladder disease, hypertensive heart disease, hypertension, overactive bladder, cough, vocal cord hypertrophy
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be maintained between 1°C and 30°C room temperature. This helps to maintain the medication's effectiveness and prevent degradation.
Pink round film-coated tablet
28 tablets/bottle, 7 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowZastaprazan Citrate 20mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Zastaprazan Citrate 20mg
Tablet · Prescription medication
Oncologic Therapeutics Co., Ltd.

Zastaprazan Citrate 20mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Zastaprazan Citrate 20mg
Orally disintegrating Tablet · Prescription medication
Onconic Therapeutics Co., Ltd.

Zastaprazan Citrate 20mg
Orally disintegrating Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.